Department of Translational Genomics Lab Pages, Student Resources, and Web Applications

News

Translational Genomics to Host Seminar by Andrew Gray from Karma Biotechnologies

 

   

Lab Rat to CEO:
Lessons from Paddling in the Shark Tank

Andrew Gray, PhD
Co-founder, CEO
Karma Biotechnologies

Thursday, September 19, 2019
12:00 – 1:00 pm
NRT 2508

Dr. Andrew Gray is an immune engineer and entrepreneur on a mission to bring treatments for autoimmunity into the 21st century. He is the cofounder and CEO of Karma Biotechnologies http://karmabiotech.com, a Los Angeles startup focused on developing Xavines™, universal therapeutics designed to shut down only the self-attacking rogue immune cells while leaving the rest of the immune system functional. Andrew was only eight years old when his mother was diagnosed with myasthenia gravis, a devastating and incurable autoimmune disease. This pivotal event – and frustration with his mother’s primitive treatment options – drove a lifetime of studying the immune system, how it works, and how it can be engineered. Andrew received his PhD in Genetics, Molecular and Cellular Biology from USC in 2011. During his studies, he helped develop a vaccine against prostate cancer, and was one of the first to show how tumors protect themselves from immune attack by hijacking the body’s natural protection systems against autoimmunity. It is these protection systems that Karma aims to reboot in autoimmune patients using Xavines™. Since receiving his PhD, he’s founded and advised multiple biotech startups, and helps assess novel technologies for several venture funds. Originally from the UK, Andrew came to the US with nothing but a place at Berkeley and a rucksack… which the airline lost. In his spare time he backpacks in the Sierra Nevada with his wife, staying off the grid until caffeine deprivation drives him back to civilization and espresso machines.

seminar flyer and contact information
pizza provided for registered attendees

 

Translational Genomics to Host Seminar by Courtney Rogers from Amgen

 

   

Amgen Research & Development and

Careers in Science

Courtney Rogers
VP, Human Resources
Amgen

Monday, September 23, 2019
2:00 – 3:00 pm
NRT LG 503/504

Courtney Rogers is a Vice President of Human Resources at Amgen, Inc., in Thousand Oaks, CA. In his current role, he leads a global HR team that supports Amgen’s Global Research and Development department—a scientific and medical organization of 4,500, doing work at the cutting edge of human therapeutics.

Courtney joined Amgen in 2003 to lead the corporate Leadership Strategy & Organizational Development group. He led the creation of Amgen’s first executive development program as well as an update of the company’s talent management, succession planning, and company-wide performance management systems. He has since held senior HR/Talent positions supporting global Information Services, Discovery Research, Translational Sciences, and Amgen’s international headquarters in Zug, Switzerland, where he both managed pan-European talent for the business and led a redesign of Amgen’s international HR structure.

Prior to joining Amgen, Courtney was President of Novations Group, Inc. a mid-sized consultancy headquartered in Boston. Core capabilities at the firm included strategy clarification, organization design, and executive development. His clients included Pfizer, Motorola, ExxonMobil, Nabisco, General Mills, and other Fortune 50 companies.

Courtney resides in Ventura, California with his wife and three daughters. He is a voracious reader, avid skier and passionate fly fisherman.

seminar flyer and contact information
register to receive notifications for future events